Orthofix Medical Company Insiders

OFIX Stock  USD 17.51  0.64  3.53%   
Orthofix Medical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Orthofix Medical stock suggests that vertually all insiders are panicking at this time. Orthofix Medical employs about 1.6 K people. The company is managed by 22 executives with a total tenure of roughly 24 years, averaging almost 1.0 years of service per executive, having 74.27 employees per reported executive.
Kimberley Elting  President
President Orthopedics

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-02-03Geoffrey C GillespieDisposed 767 @ 17.79View
2025-01-16Julie AndrewsDisposed 4655 @ 17.89View
2025-01-13Massimo CalafioreDisposed 9203 @ 17.14View
2025-01-10Massimo CalafioreDisposed 10078 @ 16.83View
2025-01-07Geoffrey C GillespieDisposed 238 @ 17.14View
2024-12-17Geoffrey C GillespieDisposed 26 @ 17.84View
Monitoring Orthofix Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Orthofix Medical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Orthofix Medical's future performance. Based on our forecasts, it is anticipated that Orthofix will maintain a workforce of slightly above 1630 employees by March 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Orthofix Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.0237) % which means that it has lost $0.0237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2086) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.45 in 2025. Return On Capital Employed is likely to rise to -0.2 in 2025. At this time, Orthofix Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 609.6 M in 2025, whereas Intangible Assets are likely to drop slightly above 57.1 M in 2025.
Common Stock Shares Outstanding is likely to rise to about 44.4 M in 2025, despite the fact that Net Loss is likely to grow to (16.9 M).

Orthofix Medical Workforce Comparison

Orthofix Medical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 31,180. Orthofix Medical holds roughly 1,634 in number of employees claiming about 5% of equities under Health Care industry.

Orthofix Medical Profit Margins

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.590.6513
Moderately Down
Slightly volatile

Orthofix Medical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthofix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthofix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Orthofix Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
1.7143
12
7
 426,029 
 132,224 
2024-03-01
0.8462
11
13
 310,214 
 452,893 
2023-12-01
2.25
9
4
 423,395 
 9,569 
2023-09-01
0.25
1
4
 7,500 
 44,545 
2023-06-01
0.625
5
8
 44,221 
 23,132 
2023-03-01
1.95
39
20
 1,619,831 
 106,796 
2022-06-01
0.8462
11
13
 113,273 
 14,233 
2022-03-01
5.0
10
2
 309,836 
 9,035 
2021-12-01
3.0
6
2
 37,180 
 3,353 
2021-09-01
0.2
1
5
 22,184 
 3,579 
2021-06-01
1.8
18
10
 224,423 
 12,684 
2020-09-01
0.2222
2
9
 43,569 
 5,122 
2020-06-01
2.75
22
8
 399,621 
 19,613 
2019-12-01
7.0
7
1
 168,938 
 5,142 
2019-09-01
0.3182
7
22
 97,826 
 48,311 
2019-06-01
2.5455
28
11
 211,083 
 27,730 
2019-03-01
0.625
5
8
 32,925 
 52,551 
2018-12-01
0.1429
2
14
 11,300 
 48,139 
2018-09-01
1.0
12
12
 43,527 
 30,795 
2018-06-01
2.9
29
10
 308,105 
 128,255 
2017-09-01
5.1667
31
6
 265,542 
 30,111 
2017-06-01
0.5
2
4
 28,967 
 57,483 
2016-12-01
1.0
2
2
 39,820 
 9,538 
2016-09-01
8.5
34
4
 332,376 
 50,000 
2016-06-01
0.6154
8
13
 134,712 
 218,168 
2016-03-01
0.0625
1
16
 30,000 
 94,025 
2015-06-01
32.0
32
1
 355,250 
 5,709 
2014-06-01
13.5
27
2
 305,546 
 32,000 
2013-09-01
7.0
14
2
 142,750 
 10,000 
2013-03-01
4.5
9
2
 176,971 
 26,667 
2012-12-01
0.125
1
8
 3,500 
 28,500 
2012-09-01
1.2083
29
24
 222,455 
 101,413 
2012-06-01
1.2222
11
9
 211,917 
 70,095 
2011-12-01
1.5
6
4
 47,201 
 42,478 
2011-06-01
2.0
2
1
 175,000 
 150,000 
2011-03-01
1.2857
18
14
 169,297 
 86,941 
2010-03-01
0.8182
9
11
 29,864 
 34,425 
2009-09-01
0.625
5
8
 80,000 
 166,500 
2009-06-01
7.5
15
2
 329,000 
 13,187 
2008-09-01
0.5455
6
11
 202,625 
 84,000 
2008-06-01
4.7778
43
9
 387,180 
 58,875 
2007-12-01
0.4286
3
7
 190,000 
 25,000 
2007-09-01
0.1304
3
23
 32,500 
 45,000 
2007-06-01
0.3261
15
46
 114,600 
 82,674 
2006-12-01
1.0
2
2
 32,000 
 6,000 
2006-09-01
2.5
5
2
 8,676 
 8,350 
2006-03-01
0.1875
3
16
 4,834 
 39,668 
2005-06-01
0.4444
20
45
 146,100 
 147,600 
2005-03-01
3.0
3
1
 90,000 
 0.00 
2004-12-01
2.8
14
5
 167,100 
 18,500 
2004-09-01
0.5
1
2
 12,500 
 12,500 
2004-06-01
0.5556
5
9
 45,000 
 61,000 
2004-03-01
0.375
3
8
 55,000 
 121,000 
2003-12-01
0.4667
7
15
 340,674 
 43,760 
2003-06-01
0.5
1
2
 160.00 
 15,000 

Orthofix Medical Notable Stakeholders

An Orthofix Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Orthofix Medical often face trade-offs trying to please all of them. Orthofix Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Orthofix Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Massimo CalafioreCEO, PresidentProfile
Kimberley EltingPresident OrthopedicsProfile
Aviva McPherronPresident QualityProfile
Jon SerbousekPresident - Global Spine BusinessProfile
Beau PEngPresident TechnologiesProfile
Tyler LipschultzPresident BiologicsProfile
Kevin KennyPresident BusinessProfile
Douglas RiceCFO OfficerProfile
Geoffrey GillespieVP ControllerProfile
BA ChemistryChief OfficerProfile
Julie DeweyChief OfficerProfile
Andres CedronChief SecretaryProfile
Stephanie WalshChief OfficerProfile
Ehab EsmailRegulatory QualityProfile
Lucas VitaleChief OfficerProfile
Suzanne ArmstrongChief OfficerProfile
Frank VizesiChief OfficerProfile
Jill MasonInterim CounselProfile
Julie AndrewsChief OfficerProfile
Roberto DonadelloSenior OperationsProfile
Mark QuickSr RelationsProfile
Dan YarbroughVice RelationsProfile

About Orthofix Medical Management Performance

The success or failure of an entity such as Orthofix Medical often depends on how effective the management is. Orthofix Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orthofix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orthofix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.47)(0.45)
Return On Capital Employed(0.21)(0.20)
Return On Assets(0.48)(0.45)
Return On Equity(0.29)(0.28)
Please note, the imprecision that can be found in Orthofix Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orthofix Medical. Check Orthofix Medical's Beneish M Score to see the likelihood of Orthofix Medical's management manipulating its earnings.

Orthofix Medical Workforce Analysis

Traditionally, organizations such as Orthofix Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Orthofix Medical within its industry.

Orthofix Medical Manpower Efficiency

Return on Orthofix Medical Manpower

Revenue Per Employee456.9K
Revenue Per Executive33.9M
Net Loss Per Employee92.7K
Net Loss Per Executive6.9M
Working Capital Per Employee156.2K
Working Capital Per Executive11.6M

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.